Stock Price Targets and Analyst Ratings

Stay on top of the latest U.S. and international stock analyst recommendations with our up-to-date list of stock price targets and analyst ratings. This page tracks newly issued analyst ratings, price targets, upgrades, downgrades, and other broker actions to help you see how Wall Street analysts view the companies you follow. Use these ratings to compare sentiment, spot shifts in outlook, and make more informed investment decisions.

Company	Action	Brokerage	Analyst	Current Price	Price Target	Rating
AA Alcoa	Upgraded by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Daniel Major Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$71.88 +8.5%	$75.00 ➝ $80.00	Neutral ➝ Buy
AAP Advance Auto Parts	Upgraded by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$58.41 -0.4%		Buy
AAP Advance Auto Parts	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Steven Zaccone Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$58.41 -0.4%	$57.00 ➝ $60.00	Neutral
AAP Advance Auto Parts	Target Raised by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Steven Shemesh Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$58.41 -0.4%	$62.00 ➝ $65.00	Sector Perform
AAP Advance Auto Parts	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$58.41 -0.4%	$60.00 ➝ $65.00	Neutral
AAP Advance Auto Parts	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Simeon Gutman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$58.41 -0.4%	$60.00 ➝ $65.00	Equal Weight
AAP Advance Auto Parts	Target Raised by	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Tristan Thomas-Martin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$58.41 -0.4%	$60.00 ➝ $65.00	Market Perform
AAP Advance Auto Parts	Target Raised by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kate McShane Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$58.41 -0.4%	$49.00 ➝ $54.00	Sell
AAP Advance Auto Parts	Reiterated by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Zachary Fadem Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$58.41 -0.4%	$50.00 ➝ $60.00	Negative
AAP Advance Auto Parts	Reiterated by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$58.41 -0.4%		Hold
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
ABNB Airbnb	Reiterated by	Sanford C. Bernstein Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$132.25 -1.5%		Outperform
ACOG Alpha Cognition	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Raghuram Selvaraju Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$5.91 +1.5%	$18.00	Buy
AJB AJ Bell	Target Raised by	Berenberg Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 643 +5.1%	GBX 490 ➝ GBX 560	Hold
AMBA Ambarella	Reiterated by	Consumer Edge Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$88.36 +5.6%		Buy
AMBA Ambarella	Target Set by	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Tore Svanberg Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$88.36 +5.6%	$90.00
AMRC Ameresco	Initiated by	Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$31.81 +5.2%		Neutral
AMTX Aemetis	Target Raised by	Ascendiant Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Edward Woo Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$2.71 +20.2%	$21.00 ➝ $22.00	Buy
ANRO Alto Neuroscience	Initiated by	Wolfe Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$21.03 -2.4%		Outperform
APLD Applied Digital	Reiterated by	Compass Point Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$46.13 -3.9%	$70.00	Buy
ATOM Atome	Target Lowered by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 59.40 -1.0%	GBX 140 ➝ GBX 115	Speculative Buy
AUTO Auto Trader Group	Target Lowered by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 452.81 +0.0%	GBX 515 ➝ GBX 445	Underweight
AVBP ArriVent BioPharma	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$26.72 -1.1%		Overweight
BCH Banco De Chile	Target Set by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$37.52 -0.6%	$39.00
BDTX Black Diamond Therapeutics	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$2.64 -25.8%		Buy
BDTX Black Diamond Therapeutics	Reiterated by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$2.64 -25.8%		Buy
BDTX Black Diamond Therapeutics	Reiterated by	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$2.64 -25.8%		Outperform
BEAT HeartBeam	Target Lowered by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Yi Chen Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$0.91 -0.7%	$5.50 ➝ $2.50	Buy
BHP BHP Group	Downgraded by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$84.55 -0.5%		Buy ➝ Neutral
BIRK Birkenstock	Reiterated by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$41.47 +4.5%	$52.50	Buy
BKE Buckle	Target Set by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mauricio Serna Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$48.98 -0.1%	$52.00
BLTE Belite Bio	Reiterated by	Benchmark Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$139.82 -3.1%		Buy
BLTE Belite Bio	Target Set by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$139.82 -3.1%	$217.00
BMI Badger Meter	Target Set by	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Nathan Jones Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$122.75 +2.1%	$140.00
BVS Bioventus	Reiterated by	Barrington Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Petusky Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$9.26 -2.5%	$14.00	Outperform
CAVA CAVA Group	Target Set by	Argus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Christine Dooley Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$81.43 +0.2%	$92.00
CAVA CAVA Group	Upgraded by	Argus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Christine Dooley Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$81.43 +0.2%		Hold ➝ Buy
CBG Close Brothers Group	Reiterated by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 464.40 +3.6%	GBX 625 ➝ GBX 625	Outperform
CCL Carnival	Target Lowered by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Patrick Scholes Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$26.07 -0.4%	$30.00 ➝ $29.00	Hold
CHRD Chord Energy	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Devin McDermott Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$143.01 +0.1%	$168.00 ➝ $175.00	Overweight
CI Cigna Group	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	A.J. Rice Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$284.68 +0.9%	$375.00 ➝ $400.00	Buy
A 17-year investing experiment investigated in Dublin (Ad) Porter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experiment called Project Prophet - and documented everything on film. Rooted in the laws of physics, this quantitative approach challenges conventional wealth-building wisdom. With 17 years of verified data behind it, Porter calls it unlike anything he has seen in nearly 30 years in the business. Watch the full investigation and decide for yourself
CIZN Citizens	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$9.41		Market Outperform
CMC Commercial Metals	Upgraded by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$71.66 +1.4%		Buy
CMI Cummins	Reiterated by	Sanford C. Bernstein Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$653.48 +2.3%		Market Perform
CMPS Compass Pathways	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Patrick R. Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$11.94 +3.0%		Buy
CMPS Compass Pathways	Reiterated by	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$11.94 +3.0%		Buy
CMPS Compass Pathways	Initiated by	Wolfe Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$11.94 +3.0%		Outperform
CNC Centene	Reiterated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	A.J. Rice Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$58.47 +1.2%	$55.00 ➝ $61.00	Neutral
CPB Campbell's	Target Set by	DA Davidson Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brian Holland Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$20.57 +2.6%	$20.00
CRBP Corbus Pharmaceuticals	Target Raised by	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Graig Suvannavejh Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$11.80 +2.5%	$40.00 ➝ $44.00	Outperform
CRK Comstock Resources	Target Lowered by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Devin McDermott Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$13.74 -2.6%	$19.00 ➝ $18.00	Equal Weight
CRM Salesforce	Reiterated by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$179.79 +2.0%		Buy
CRS Carpenter Technology	Target Raised by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Gautam Khanna Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$438.14 0.0%	$450.00 ➝ $470.00	Buy
CSX CSX	Target Raised by	Argus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$45.75 -0.3%	$42.00 ➝ $52.00	Buy
CTEC ConvaTec Group	Target Lowered by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 197 -3.2%	GBX 307 ➝ GBX 294	Overweight
CTRE CareTrust REIT	Target Set by	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Vikram Malhotra Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$41.12 +0.3%	$45.00
CVX Chevron	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Devin McDermott Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$190.88 -0.1%	$212.00 ➝ $214.00	Overweight
CWK Cushman & Wakefield	Target Set by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Julien Blouin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$12.77 -0.4%	$17.00	Buy
DAVA Endava	Target Set by	CLSA Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$3.25 -2.8%	$5.00
DAVA Endava	Reiterated by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Puneet Jain Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$3.25 -2.8%	$9.00 ➝ $5.00	Neutral ➝ Underweight
DAVA Endava	Target Lowered by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	James Faucette Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$3.25 -2.8%	$8.00 ➝ $4.00	Equal Weight
DAVA Endava	Target Lowered by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Bryan Bergin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$3.25 -2.8%	$6.00 ➝ $4.00	Hold
DAVA Endava	Reiterated by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Bryan Bergin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$3.25 -2.8%		Buy
DDOG Datadog	Target Set by	DA Davidson Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Gil Luria Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$222.76 +2.2%	$250.00
DE Deere & Company	Target Lowered by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ross Gilardi Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$528.47 -0.5%	$672.00 ➝ $607.50	Neutral
DE Deere & Company	Target Lowered by	DA Davidson Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$528.47 -0.5%	$775.00 ➝ $685.00	Buy
DE Deere & Company	Target Lowered by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$528.47 -0.5%	$625.00 ➝ $595.00	Neutral
DE Deere & Company	Target Lowered by	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$528.47 -0.5%	$580.00 ➝ $525.00	Neutral
DE Deere & Company	Target Raised by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Tami Zakaria Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$528.47 -0.5%	$550.00 ➝ $560.00	Neutral
DECK Deckers Outdoor	Downgraded by	KGI Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$103.87 +1.2%	$117.00	Outperform ➝ Neutral
DECK Deckers Outdoor	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Tom Nikic Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$103.87 +1.2%	$138.00	Buy
DECK Deckers Outdoor	Reiterated by	KeyCorp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$103.87 +1.2%		Sector Weight
DECK Deckers Outdoor	Reiterated by	Sanford C. Bernstein Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Aneesha Sherman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$103.87 +1.2%	$105.00	Market Perform
DECK Deckers Outdoor	Target Set by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joseph Civello Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$103.87 +1.2%	$132.00 ➝ $125.00	Buy
DELL Dell Technologies	Upgraded by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Erik Woodring Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$295.47 +16.9%		Underweight ➝ Buy
DELL Dell Technologies	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Aaron Rakers Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$295.47 +16.9%	$180.00 ➝ $270.00	Overweight
DG Dollar General	Target Lowered by	Loop Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$105.60 +0.5%	$145.00 ➝ $110.00	Hold
DG Dollar General	Downgraded by	Gordon Haskett Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$105.60 +0.5%	$140.00 ➝ $110.00	Buy ➝ Hold
DHLGY DHL Group	Upgraded by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$28.95 +3.0%		Hold ➝ Buy
DLTR Dollar Tree	Reiterated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$94.84 -0.9%	$132.00	Buy
DNLI Denali Therapeutics	Target Set by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$18.89 -2.2%	$31.00
DOC Healthpeak Properties	Reiterated by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Richard Hill Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$19.79 +0.7%	$20.00	Overweight
EEFT Euronet Worldwide	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mayank Tandon Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$66.26 -0.4%	$85.00	Buy
EHC Encompass Health	Target Set by	Leerink Partners Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Whit Mayo Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$105.28 +0.8%	$152.00
EL Estee Lauder Companies	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Filippo Falorni Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$86.44 +9.5%	$92.00 ➝ $110.00	Buy
ELBM Electra Battery Materials	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$0.61 -0.1%	$2.00	Buy
ELBM Electra Battery Materials	Reiterated by	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$0.61 -0.1%		Buy
ELV Elevance Health	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	A.J. Rice Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$393.30 +0.9%	$400.00 ➝ $460.00	Buy
ENOV Enovis	Reiterated by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ryan Zimmerman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$24.46 -0.5%	$39.00	Buy
ENPH Enphase Energy	Reiterated by	Roth Mkm Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$63.56 +1.9%		Buy
ENPH Enphase Energy	Target Set by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$63.56 +1.9%	$85.00
The chokepoint supplier behind SpaceX's $1.75 trillion empire (Ad) When Musk laughed and said 'you need transformers to run transformers,' it wasn't a joke - it was a confession. The world's largest supercomputer requires power equipment that takes 120 weeks to build, and Musk built Colossus in just 122 days. One small American company is positioned to close that gap faster than anyone else, yet Wall Street still prices it like an afterthought. Dylan Jovine has the full story and the ticker. See the stock Musk's own words pointed to right here
ENS Enersys	Target Raised by	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Noah Kaye Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$234.53 -1.8%	$210.00 ➝ $250.00	Outperform
ENS Enersys	Reiterated by	Roth Mkm Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$234.53 -1.8%	$265.00	Buy
EOSE Eos Energy Enterprises	Initiated by	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Sean Milligan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$8.15 -0.3%	$11.00	Buy
EQR Equity Residential	Reiterated by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$65.85 +0.1%		Overweight
ESNT Essent Group	Initiated by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Rowland Mayor Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$61.11 -1.3%	$68.00	Outperform ➝ Sector Perform
ESTC Elastic	Initiated by	William Blair Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$54.86 +1.9%		Outperform
EXE Expand Energy	Target Set by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$97.22 -0.4%	$139.00
EZJ easyJet	Target Lowered by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 370.20 +5.7%	GBX 415 ➝ GBX 405	Outperform
FANG Diamondback Energy	Reiterated by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Devin McDermott Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$200.25 -0.4%	$229.00	Overweight
FDX FedEx	Reiterated by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$397.69 +2.3%		Buy
FDX FedEx	Reiterated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Thomas Wadewitz Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$397.69 +2.3%	$446.00 ➝ $445.00	Buy
FENC Adherex Technologies	Target Raised by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Raghuram Selvaraju Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$9.90 -0.8%	$13.00 ➝ $16.00	Buy
FROG JFrog	Target Raised by	KeyCorp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jason Celino Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$72.95 +2.1%	$83.00 ➝ $86.00	Overweight
FUTU Futu	Reiterated by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$91.05 -26.5%	$87.00	Overweight ➝ Neutral
GEVO Gevo	Reiterated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$1.76 +3.2%	$2.00	Neutral
GNRC Generac	Upgraded by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Tanner James Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$267.33 +7.9%	$239.00 ➝ $302.00	Hold ➝ Buy
GNRC Generac	Target Set by	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Tanner James Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$267.33 +7.9%	$302.00
GNRC Generac	Upgraded by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Tanner James Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$267.33 +7.9%	$302.00	Hold ➝ Buy
HAE Haemonetics	Upgraded by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Craig Bijou Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$64.06 +3.4%	$72.00 ➝ $80.00	Neutral ➝ Buy
HIMS Hims & Hers Health	Target Raised by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jailendra Singh Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$23.77 -1.0%	$18.00 ➝ $23.00	Hold
HLCL Helical	Reiterated by	Berenberg Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 193.60 +2.3%	GBX 216 ➝ GBX 216	Hold
HLNE Hamilton Lane	Target Raised by	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Chris Kotowski Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$90.11 +1.7%	$171.00 ➝ $179.00	Outperform
HLNE Hamilton Lane	Reiterated by	Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$90.11 +1.7%		Outperform
HLNE Hamilton Lane	Target Lowered by	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brennan Hawken Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$90.11 +1.7%	$108.00 ➝ $102.00	Outperform
HLNE Hamilton Lane	Target Set by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$90.11 +1.7%	$148.00	Buy
HRMY Harmony Biosciences	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$30.30 -0.6%		Buy
HUM Humana	Reiterated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	A.J. Rice Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$308.03 +1.4%	$262.00 ➝ $320.00	Neutral
IBM International Business Machines	Target Set by	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Grossman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$257.35 +1.7%	$290.00
IBST Ibstock	Target Lowered by	Berenberg Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 97.90 -1.9%	GBX 135 ➝ GBX 120	Hold
IDYA IDEAYA Biosciences	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$29.27 -0.9%		Overweight
IMAX IMAX	Target Raised by	Benchmark Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mike Hickey Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$39.00 +15.1%	$44.00 ➝ $60.00	Buy
IMAX IMAX	Reiterated by	Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$39.00 +15.1%	$60.00	Market Perform
IMMX Immix Biopharma	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Robert Burns Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$8.78 +1.2%	$15.00 ➝ $20.00	Buy
IMUX Immunic	Initiated by	Wolfe Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$13.37 +8.7%		Outperform
IMUX Immunic	Target Lowered by	B. Riley Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	William Woods Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$13.37 +8.7%	$40.00 ➝ $27.00	Buy
IMVT Immunovant	Target Raised by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Danielle Brill Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$34.82 +2.0%	$23.00 ➝ $30.00	Hold
INSP Inspire Medical Systems	Target Set by	Summit Redstone Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$43.56 -2.6%	$39.00
INSP Inspire Medical Systems	Downgraded by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$43.56 -2.6%	$39.00	Neutral ➝ Underperform
INTU Intuit	Target Lowered by	Susquehanna Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$310.02 +1.0%	$640.00 ➝ $550.00	Positive
INTU Intuit	Target Lowered by	HSBC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$310.02 +1.0%	$897.00 ➝ $707.00	Buy
INTU Intuit	Target Lowered by	Argus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$310.02 +1.0%	$580.00 ➝ $480.00	Buy
IOT Samsara	Reiterated by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$31.15 +3.3%		Buy
JAZZ Jazz Pharmaceuticals	Target Raised by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Amsellem Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$241.83 +1.0%	$232.00 ➝ $301.00	Overweight
JMAT Johnson Matthey	Reiterated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 2,163.87 +1.6%	GBX 2,200 ➝ GBX 2,200	Neutral
KGF Kingfisher	Reiterated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 294.76 +0.5%	GBX 295 ➝ GBX 295	Neutral
LION Lionsgate Studios	Reiterated by	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$14.18 +9.8%	$15.00	Outperform
LION Lionsgate Studios	Reiterated by	Barrington Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Patrick Sholl Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$14.18 +9.8%	$14.50	Outperform
LSCC Lattice Semiconductor	Target Raised by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Melissa Weathers Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$143.23 +2.8%	$150.00 ➝ $175.00	Buy
LSPD Lightspeed Commerce	Target Lowered by	Benchmark Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mark Palmer Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$8.73 +4.3%	$18.00 ➝ $16.00	Buy
LULU lululemon athletica	Target Lowered by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Anna Andreeva Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$126.17 -0.5%	$190.00 ➝ $130.00	Neutral
Elon’s Biggest Launch Ever: 15x Bigger Than SpaceX (Ad) The Man Who Called Nvidia Before It Soared 1,000% Issues New Elon Musk BUY Alert Luke Lango was ranked America's #1 stock picker in 2020. He was mentored by two hedge fund billionaires from the Soros network and trained at Caltech. His readers have had the chance to see gains as high as AMD +8,500%... Nvidia +5,000%... Tesla +3,500%... Palantir +1,000%... and Apple +890%. Now he's releasing his next big pick.
LZ LegalZoom.com	Target Lowered by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ronald Josey Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$6.34 -1.8%	$8.50 ➝ $7.50	Neutral
MAIN Main Street Capital	Target Set by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Finian O'Shea Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$49.43 -3.1%	$50.00	Equal Weight
MKS Marks and Spencer Group	Target Lowered by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 347.20 -1.0%	GBX 410 ➝ GBX 390	Buy
MNDY monday.com	Target Lowered by	Tigress Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ivan Feinseth Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$79.01 +3.6%	$310.00 ➝ $165.00	Buy
MOH Molina Healthcare	Reiterated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	A.J. Rice Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$181.94 +0.4%	$180.00 ➝ $202.00	Neutral
MRVL Marvell Technology	Target Raised by	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Tore Svanberg Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$197.75 +3.7%	$140.00 ➝ $210.00	Buy
MSFT Microsoft	Reiterated by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$418.58 -0.1%		Buy
MTG MGIC Investment	Initiated by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Rowland Mayor Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$26.07 -0.4%	$28.00	Sector Perform
MTSI MACOM Technology Solutions	Target Raised by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Tom O'Malley Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$383.40 +0.8%	$400.00 ➝ $450.00	Overweight
NBIX Neurocrine Biosciences	Initiated by	Sanford C. Bernstein Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jeffrey Walch Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$156.83 +0.9%	$221.00	Outperform
NCLH Norwegian Cruise Line	Reiterated by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Trey Bowers Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$16.31 -1.0%	$20.00 ➝ $19.00	Overweight
NCLH Norwegian Cruise Line	Target Lowered by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Patrick Scholes Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$16.31 -1.0%	$25.00 ➝ $20.00	Buy
NDSN Nordson	Target Raised by	BNP Paribas Exane Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Andrew Buscaglia Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$288.08 +0.5%	$285.00 ➝ $290.00	Neutral
NET Cloudflare	Reiterated by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$215.19 +1.2%		Outperform
NIO NIO	Reiterated by	Sanford C. Bernstein Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$5.26 -6.2%	$6.00	Market Perform
NMIH NMI	Target Set by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$37.55 -0.6%	$46.00
NMIH NMI	Initiated by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Rowland Mayor Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$37.55 -0.6%	$46.00	Outperform
NOG Northern Oil and Gas	Reiterated by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$23.61 -0.1%	$29.00	Underweight
NOK Nokia	Reiterated by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$15.67 +10.5%		Overweight
NTES NetEase	Reiterated by	Benchmark Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$116.79 +2.1%		Buy
NTNX Nutanix	Reiterated by	Rosenblatt Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Blair Abernethy Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$46.59 +4.3%	$60.00	Buy
NVDA NVIDIA	Target Raised by	CICC Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$216.76 -1.3%	$240.60 ➝ $268.30	Outperform
NVDA NVIDIA	Target Raised by	Daiwa Securities Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$216.76 -1.3%	$215.00 ➝ $255.00	Outperform
NVDA NVIDIA	Target Raised by	Citic Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$216.76 -1.3%	$242.00 ➝ $315.00	Buy
OFIX Orthofix Medical	Target Lowered by	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Thomas Stephan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$10.75 +3.2%	$18.00 ➝ $15.00	Buy
OFIX Orthofix Medical	Target Lowered by	Barrington Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Petusky Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$10.75 +3.2%	$17.00 ➝ $15.00	Outperform
OKLO Oklo	Target Set by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$66.95 +2.9%	$80.00
OKLO Oklo	Initiated by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$66.95 +2.9%	$80.00	Buy
OLMA Olema Pharmaceuticals	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Emily Bodnar Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$13.56 -3.6%		Buy
ORIC Oric Pharmaceuticals	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$8.38 -0.9%		Overweight
OSW OneSpaWorld	Target Raised by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Gregory Miller Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$23.96 -0.7%	$25.00 ➝ $28.00	Buy
PGR Progressive	Reiterated by	Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Meyer Shields Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$198.03 -0.5%		Market Perform
PGR Progressive	Target Set by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$198.03 -0.5%	$208.00
PIII P3 Health Partners	Reiterated by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ryan Langston Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$13.15 -5.2%	$3.00 ➝ $14.00	Hold
PLTR Palantir Technologies	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$136.62 -0.6%	$138.00	Neutral
PSA Public Storage	Target Raised by	BNP Paribas Exane Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$305.40 +0.1%	$331.00 ➝ $335.00	Outperform
QTTB Q32 Bio	Initiated by	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joseph Catanzaro Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$5.82 +5.7%	$14.00	Outperform
RAMP LiveRamp	Target Set by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$37.71 -0.3%	$38.50
RBLX Roblox	Target Set by	DA Davidson Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Wyatt Swanson Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$47.25 +2.4%	$45.00
RCL Royal Caribbean Cruises	Target Lowered by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Patrick Scholes Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$258.73 -0.6%	$318.00 ➝ $297.00	Hold
RDN Radian Group	Initiated by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Rowland Mayor Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$36.78 -1.2%	$47.00	Sector Perform ➝ Outperform
RIGL Rigel Pharmaceuticals	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joseph Pantginis Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$29.30 +0.4%	$57.00	Buy
RIO Rio Tinto	Downgraded by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$104.28 -0.5%		Buy ➝ Neutral
RL Ralph Lauren	Reiterated by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Robert Drbul Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$376.63 +0.5%	$450.00	Buy
RL Ralph Lauren	Target Raised by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Adrienne Yih Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$376.63 +0.5%	$430.00 ➝ $439.00	Overweight
RL Ralph Lauren	Target Set by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ike Boruchow Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$376.63 +0.5%	$400.00 ➝ $415.00	Overweight
RL Ralph Lauren	Reiterated by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$376.63 +0.5%	$437.00	Buy
RL Ralph Lauren	Target Set by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jay Sole Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$376.63 +0.5%	$511.00
RMTI Rockwell Medical	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Raghuram Selvaraju Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$0.79 -2.2%	$2.00	Buy
ROST Ross Stores	Reiterated by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ike Boruchow Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$231.74 +6.7%	$235.00 ➝ $245.00	Overweight
I’m sounding the alarm (Ad) Meta is cutting 10% of its workforce. Microsoft offered voluntary retirement to 7% of U.S. employees. Oracle, Amazon, Snap, and Block have done the same. Most assume this is about AI - but investor Porter Stansberry says the real driver runs far deeper. Goldman Sachs estimates 12,400 Americans are being financially harmed every day by this shift, while others grow wealthier. Stansberry - who predicted the internet economy's rise and recommended Amazon, Qualcomm, and Texas Instruments before they were household names - is now releasing a new investigation he calls The Final Displacement. Watch Stansberry's full investigation and see which companies to buy and sell
ROST Ross Stores	Reiterated by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$231.74 +6.7%	$270.00	Buy
ROST Ross Stores	Reiterated by	Sanford C. Bernstein Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$231.74 +6.7%	$230.00	Market Perform
ROST Ross Stores	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jay Sole Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$231.74 +6.7%	$227.00 ➝ $232.00	Neutral
ROST Ross Stores	Reiterated by	Telsey Advisory Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Dana Telsey Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$231.74 +6.7%		Outperform
ROST Ross Stores	Reiterated by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$231.74 +6.7%	$257.00	Buy
ROST Ross Stores	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Paul Lejuez Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$231.74 +6.7%	$261.00 ➝ $270.00	Buy
RPID Rapid Micro Biosystems	Target Lowered by	Lake Street Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Thomas Flaten Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$2.10 +1.2%	$8.00 ➝ $7.00	Buy
RRC Range Resources	Target Set by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$40.93 -0.5%	$50.00
RSG Resolute Mining	Reiterated by	Berenberg Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 63.60 -6.7%	GBX 89 ➝ GBX 89	Buy
SABS SAB Biotherapeutics	Initiated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Samantha Semenkow Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$3.92 +2.9%	$11.00	Buy
SBLK Star Bulk Carriers	Reiterated by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$26.38 -2.0%	$32.00	Buy
SG Sweetgreen	Upgraded by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Rahul Krotthapalli Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$9.62 +7.1%	$8.00 ➝ $13.00	Neutral ➝ Overweight
SHEL Shell	Reiterated by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 3,205 -1.0%		Buy
SHLS Shoals Technologies Group	Reiterated by	Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$10.07 +5.4%		Buy
SIG Signet Jewelers	Reiterated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mauricio Serna Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$81.47 +0.1%	$121.00	Buy
SMIN Smiths Group	Reiterated by	Berenberg Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 2,498 +0.4%	GBX 3,000 ➝ GBX 3,000	Buy
SMIN Smiths Group	Target Lowered by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 2,498 +0.4%	GBX 2,830 ➝ GBX 2,810	Overweight
SMMT Summit Therapeutics	Downgraded by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mitchell S. Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$16.76 -4.1%		Buy ➝ Neutral
SMMT Summit Therapeutics	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$16.76 -4.1%		Overweight
SMR NuScale Power	Initiated by	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$11.54 +1.9%	$12.00	Neutral
SMTC Semtech	Target Raised by	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Rick Schafer Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$162.91 +11.2%	$110.00 ➝ $150.00	Outperform
SNDX Syndax Pharmaceuticals	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Andres Y. Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$20.20 +2.2%	$40.00	Buy
SNOW Snowflake	Reiterated by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$172.24 +4.0%		Buy
SNSE Sensei Biotherapeutics	Initiated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Samantha Semenkow Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$18.04 +2.8%	$55.00	Buy
SPOT Spotify Technology	Target Raised by	Rosenblatt Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Barton Crockett Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$527.50 +7.7%	$500.00 ➝ $534.00	Neutral
SPOT Spotify Technology	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Manan Gosalia Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$527.50 +7.7%	$590.00 ➝ $610.00	Overweight
SPOT Spotify Technology	Target Raised by	Citizens Jmp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Matthew Condon Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$527.50 +7.7%	$600.00 ➝ $625.00	Market Outperform
SPOT Spotify Technology	Target Raised by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kannan Venkateshwar Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$527.50 +7.7%	$500.00 ➝ $565.00	Overweight
SPOT Spotify Technology	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Steven Cahall Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$527.50 +7.7%	$580.00 ➝ $600.00	Overweight
SSE SSE	Reiterated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 2,408.55 0.0%	GBX 2,350 ➝ GBX 2,350	Neutral
STLA Stellantis	Target Set by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$7.55 -0.2%	$9.00
STLA Stellantis	Reiterated by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$7.55 -0.2%		Hold
SUI Sun Communities	Target Lowered by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Richard Hightower Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$127.24 +0.7%	$148.00 ➝ $147.00	Overweight
SUI Sun Communities	Upgraded by	Colliers Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$127.24 +0.7%	$150.00	Neutral ➝ Buy
SYF Synchrony Financial	Initiated by	Loop Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Dominick Gabriele Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$71.92 -0.1%	$81.00	Hold
TDC Teradata	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Yitchuin Wong Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$33.64 +2.6%		Market Outperform
TENB Tenable	Target Set by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kingsley Crane Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$25.63 +1.8%	$30.00
TENB Tenable	Target Raised by	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Adam Borg Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$25.63 +1.8%	$22.00 ➝ $26.00	Hold
TENB Tenable	Target Raised by	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mike Cikos Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$25.63 +1.8%	$26.00 ➝ $30.00	Buy
TENB Tenable	Reiterated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$25.63 +1.8%	$27.00	Hold
TGT Target	Reiterated by	Roth Mkm Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$126.28 +0.1%	$114.00	Neutral
TKR Timken	Target Raised by	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Bryan Blair Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$119.61 +0.6%	$132.00 ➝ $137.00	Outperform
TKR Timken	Target Set by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$119.61 +0.6%	$128.00
TPT Topps Tiles	Target Lowered by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		GBX 34.50 +3.3%	GBX 46 ➝ GBX 33	Hold
TTWO Take-Two Interactive Software	Target Lowered by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Alec Brondolo Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$228.25 -4.1%	$293.00 ➝ $287.00	Overweight
TTWO Take-Two Interactive Software	Reiterated by	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$228.25 -4.1%		Outperform
TTWO Take-Two Interactive Software	Reiterated by	Benchmark Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$228.25 -4.1%		Buy
TWST Twist Bioscience	Target Set by	Leerink Partners Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Puneet Souda Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$60.03 +2.0%	$80.00
TX Ternium	Reiterated by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$46.67 +4.1%	$57.00	Buy
TXN Texas Instruments	Upgraded by	KeyCorp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	John Vinh Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$314.64 +5.4%		Overweight ➝ Sector Weight
TXN Texas Instruments	Downgraded by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$314.64 +5.4%		Neutral
TXN Texas Instruments	Initiated by	Sanford C. Bernstein Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$314.64 +5.4%		Market Perform
TXN Texas Instruments	Upgraded by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Blayne Curtis Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$314.64 +5.4%		Hold ➝ Buy
TZOO Travelzoo	Target Raised by	Ascendiant Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Edward Woo Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$9.90 +4.3%	$22.00 ➝ $23.00	Buy
UNH UnitedHealth Group	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	A.J. Rice Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$388.58 +1.6%	$410.00 ➝ $460.00	Buy
URBN Urban Outfitters	Target Lowered by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Adrienne Yih Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$73.09 -0.9%	$102.00 ➝ $100.00	Overweight
VIK Viking	Upgraded by	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Patrick Scholes Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$85.16 +1.5%	$75.00 ➝ $102.00	Hold ➝ Buy
VIPS Vipshop	Reiterated by	Benchmark Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$14.10 -2.9%		Hold
VTR Ventas	Target Set by	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Vikram Malhotra Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$88.26 +0.3%	$98.00
WDAY Workday	Reiterated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$128.48 +5.4%	$140.00	Hold
WDAY Workday	Reiterated by	Sanford C. Bernstein Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$128.48 +5.4%	$216.00	Outperform
WDAY Workday	Reiterated by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$128.48 +5.4%		Market Perform
WDAY Workday	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$128.48 +5.4%		Market Perform
WDAY Workday	Upgraded by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$128.48 +5.4%		Overweight ➝ Buy
WDAY Workday	Target Lowered by	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Scott Berg Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$128.48 +5.4%	$300.00 ➝ $180.00	Buy
WDAY Workday	Target Raised by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Billy Fitzsimmons Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$128.48 +5.4%	$135.00 ➝ $145.00	Neutral
WDAY Workday	Target Lowered by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Steven Enders Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$128.48 +5.4%	$148.00 ➝ $139.00	Neutral
WDAY Workday	Reiterated by	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$128.48 +5.4%		Hold
WDAY Workday	Reiterated by	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$128.48 +5.4%		Outperform
WDAY Workday	Reiterated by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$128.48 +5.4%		Outperform
WDAY Workday	Target Set by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$128.48 +5.4%	$140.00
WDAY Workday	Reiterated by	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$128.48 +5.4%	$165.00	Outperform
WDAY Workday	Target Raised by	KeyCorp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jason Celino Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$128.48 +5.4%	$155.00 ➝ $158.00	Overweight
WDAY Workday	Reiterated by	Wolfe Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$128.48 +5.4%	$160.00	Outperform
WDAY Workday	Target Set by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Turrin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$128.48 +5.4%	$180.00 ➝ $185.00	Overweight
WELL Welltower	Target Set by	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Vikram Malhotra Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$216.25 +0.1%	$239.00
WMS Advanced Drainage Systems	Target Lowered by	KeyCorp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jeffrey Hammond Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$131.28 -2.9%	$198.00 ➝ $185.00	Overweight
WMS Advanced Drainage Systems	Target Set by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$131.28 -2.9%	$205.00
WMS Advanced Drainage Systems	Reiterated by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$131.28 -2.9%	$168.00	Outperform
WMT Walmart	Target Set by	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$120.21 -0.9%	$141.00
WMT Walmart	Reiterated by	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$120.21 -0.9%		Outperform
WMT Walmart	Reiterated by	KeyCorp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$120.21 -0.9%		Overweight
WMT Walmart	Target Lowered by	BNP Paribas Exane Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Chris Bottiglieri Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$120.21 -0.9%	$147.00 ➝ $146.00	Outperform
WMT Walmart	Reiterated by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Robert Drbul Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$120.21 -0.9%	$145.00	Buy
WMT Walmart	Reiterated by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Steven Shemesh Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$120.21 -0.9%	$140.00 ➝ $137.00	Outperform
WRBY Warby Parker	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Paul Lejuez Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$24.92 +1.7%		Market Outperform
WSM Williams-Sonoma	Target Set by	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Seth Sigman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$192.03 +0.0%	$186.00 ➝ $190.00	Equal Weight
WSM Williams-Sonoma	Target Set by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Steven Shemesh Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$192.03 +0.0%	$191.00 ➝ $192.00	Outperform
WSM Williams-Sonoma	Reiterated by	Telsey Advisory Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Cristina Fernandez Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$192.03 +0.0%		Outperform
WSM Williams-Sonoma	Target Set by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$192.03 +0.0%	$210.00
WSM Williams-Sonoma	Target Set by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Zachary Fadem Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$192.03 +0.0%	$185.00 ➝ $190.00	Equal Weight
WSM Williams-Sonoma	Target Set by	Telsey Advisory Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Cristina Fernandez Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$192.03 +0.0%	$225.00
ZG Zillow Group	Reiterated by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$36.59 -1.8%		Neutral
ZM Zoom Communications	Target Raised by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Thomas Blakey Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$107.46 +11.1%	$87.00 ➝ $104.00	Neutral
ZM Zoom Communications	Target Set by	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Josh Baer Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$107.46 +11.1%	$105.00
ZM Zoom Communications	Reiterated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$107.46 +11.1%	$118.00	Buy
ZM Zoom Communications	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ryan MacWilliams Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$107.46 +11.1%	$90.00 ➝ $105.00	Equal Weight
ZM Zoom Communications	Target Raised by	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Rishi Jaluria Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$107.46 +11.1%	$110.00 ➝ $130.00	Outperform
ZM Zoom Communications	Target Raised by	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Siti Panigrahi Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$107.46 +11.1%	$100.00 ➝ $120.00	Outperform
ZM Zoom Communications	Upgraded by	KeyCorp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jackson Ader Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$107.46 +11.1%		Underweight ➝ Sector Weight
ZM Zoom Communications	Target Raised by	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Allan Verkhovski Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$107.46 +11.1%	$100.00 ➝ $125.00	Buy
ZM Zoom Communications	Target Raised by	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Joshua Reilly Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$107.46 +11.1%	$100.00 ➝ $130.00	Buy
ZM Zoom Communications	Target Raised by	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	James Fish Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$107.46 +11.1%	$91.00 ➝ $107.00	Neutral
ZM Zoom Communications	Target Raised by	Rosenblatt Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Catharine Trebnick Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$107.46 +11.1%	$115.00 ➝ $130.00	Buy
ZNTL Zentalis Pharmaceuticals	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		$4.08 -1.5%	$10.00	Buy
ZTS Zoetis	Target Lowered by	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jonathan Block Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	$81.31 +1.6%	$105.00 ➝ $95.00	Hold

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Friday at 12:53 PM ET.

Stock Ratings and Recommendations: Understanding Analyst Ratings

Written by MarketBeat Staff

July 5, 2023

Key Points

Stock analysts give ratings to companies based on their research and insights.
Analysis comes from the buy side (fund companies, investment managers) or sell side (brokers, banks).
Analysts use different methodologies, so investors should always look into why a particular rating was given.
5 stocks we like better than EXA)

You'll often hear a particular stock called a "buy" or "sell," but who exactly makes these calls? Ratings and recommendations come from stock analysts, who research different securities and work for various institutions, brokerage firms and other financial companies.

Analyst ratings are designed to give additional information to investors beyond just what the company is saying, but are analyst ratings reliable? In this article, we'll discuss how to read analyst ratings, what goes into their decision-making process and how potential conflicts of interest influence analyst stock ratings.

What Are Analyst Ratings?

A stock rating is a simple heuristic given by analysts who review the firm's financial statements, listen to conference calls, chat with company executives and compare the stock to others in the industry or sector. Finally, an analyst uses all this information to produce a simple recommendation and price target.

When a public analyst goes on CNBC or the "Wall Street Journal" to give a "buy" or "sell" rating on a particular stock, they take all their research and pare it down into a simple designation. While there's no true consensus on what constitutes a buy or sell rating, an analyst usually does have "skin in the game" when devising ratings.

Ratings often pair with price targets, which put a hard number on what the analysts believe the company stock should be worth. So, for example, you might see an analyst report something like, "Buy NVIDIA Inc. (NASDAQ: NVDA), price target $350," which means that particular analyst believes investors should buy NVDA shares up to a price of $350 per share.

Analyst ratings infographic: What you need to know

What Does a Stock Analyst Do?

A stock analyst is a market professional with the skills to interpret financial data and the connections within companies to speak on the record with higher-ups. Analysts generally fall into one of two different camps: buy-side or sell-side. These positions will seem similar, but they tend to be employed by various institutions and have different responsibilities in their particular market "territories."

Buy-side analysts: Analysts on the buy side tend to work for funds, such as ETF providers or hedge funds. They don't dig as deeply into company financial data or conference calls as sell-siders. Instead, they focus on general areas or industries where their funds have vested interests. In addition, buy-side analysts often forge relationships with sell-side analysts for individual stock research. A buy-side analyst's primary goal is to find and utilize the most accurate and dependable sell-side analysts.
Sell-side analysts: If buy-side analysts work for funds (i.e., institutions that buy securities), you can probably guess which type of institution employs sell-side analysts. Brokers, banks and other firms that sell securities to investors use sell-side analysts to give reports to the public. While buy-side analysts also give ratings and price targets, the reported "buy" and "sell" ratings in financial media typically come from folks on the sell side.

Buy and sell-side analysts often use different rating systems when making their recommendations. You might even find two sell-side analysts with similar "buy" recommendations with vastly different price targets in the same stock. As a result, you'll need to familiarize yourself with the various methodologies analysts use to utilize their research correctly.

What Ratings Do Analysts Give?

Stock analyst ratings don't follow a strict structure, although most have roughly the same grading system for the securities they review. The labels may differ slightly (i.e., overweight vs. outperform), but the five most common analyst ratings go like this.

Buy

Analysts bullish on a particular security will give it a "buy" rating and set a price target above the current market price. In addition, if the analyst considers the stock one of the best in the industry or sector, you'll sometimes see a "strong buy" rating attached.

Hold

A "hold" rating is typically the lowest rating a sell-side analyst gives a stock. "Hold" means the analyst projects the stock to meet the return of the market averages, making it an unspectacular investment. Stocks rated "hold" may still have a price target above the current price, but it's not likely to surpass the return of a major index like the S&P 500.

Sell

Analysts are usually apprehensive about giving a stock a "sell" rating. For example, suppose a "hold" rating indicates indecision over the stock's future. In this scenario, a "sell" rating is issued when an analyst finds something unappealing, such as questionable accounting tactics or cratering sales growth.

Underperform

Analysts won't always give a firm "buy" or "sell" rating on stock but will instead label it "underperform" or "outperform." "Underperform" means the analyst expects the stock not to keep up with the market. It doesn't necessarily mean the analyst predicts a crash but indicates a lack of confidence in the shares.

Outperform

"Outperform" is the opposite of "underperform," meaning the analyst expects the stock to do better than the market average. It's usually considered a less confident rating than "buy."

Example of an Analyst Rating

You can use MarketBeat Analyst Ratings to find ranges and aggregates from buy- and sell-side analysts across the financial media. For example, here's a stock that analysts usually love: Alphabet Inc. (NASDAQ: GOOG).

Overview of stock analysis on GOOG Using MarketBeat's tools, you can find ratings from prominent analysts from multiple periods. Alphabet is currently labeled a "moderate buy" based on MarketBeat's consensus from 17 analysts. You'll get the consensus price target and the highest and lowest from the analysts surveyed.

Marketbeat's tools detailing analyst ratings

Looking at analyst recommendations over time is another helpful tool. For example, you can view the different levels of coverage over the last few years, which analysts changed their ratings and how the price targets vary from month to month. If an analyst can't get a good read on a particular stock they've been covering, they might choose to withhold their grade, which is one reason why the number of available ratings can change over time.

Overview of analyst ratings on MarketBeat Analysts from both sides of the aisle can be found on MarketBeat, ranging from large firms like JPMorgan Chase and Co. (NYSE: JPM) to smaller investment banks like Roth Capital. Some institutions like UBS Group offer both buy-side and sell-side ratings and analysis. These graphs show that even analysts with similar ratings can have vastly different price targets, so always understand the reasoning behind an analyst's view.

How to Use Analyst Ratings

Here are a few pointers on incorporating analyst ratings into your investment research.

Step 1: Don't rely on a single analyst.

Using an array of analysts (buy- and sell-side) gives inventors the most possible information. Don't just look for analysts with similar opinions as yourself — ensure you understand the pros and cons of each investment you make by incorporating positive and negative views, if possible.

Step 2: Compare analyst ratings across the industry or sector.

It's easy to slap a "buy" rating on a stock and predict a winner, but comparing stocks against others in the sector can offer insight into the rating. For example, if a stock is rated "buy" in the information technology sector, but a dozen others are rated "strong buy" by the same analyst, where is your capital best served?

Step 3: Consider your own goals and risk tolerance.

You might find stocks rated "strong buy" in your research in sectors you wish to avoid. That's fine! There are thousands of securities across dozens of industries in the public markets, and you don't need to purchase every share that comes with a "buy" rating. Instead, stick to your investment plan.

Step 4: Don't stubbornly stick to your original assessments.

Following your investment plan and using analyst ratings as guidelines are practical steps, but things can change over time. Today's "strong buy" stocks could be "strong sell" stocks down the road. Using an aggregate of analysts' ratings can help investors view stocks from a higher level. For example, if the number of "buy" ratings on a stock drops 40% over a few years, you might want to take a closer look at that particular company.

Why Are Analyst Ratings Important?

Checking out analyst ratings isn't a necessary step for investing, but it can be helpful for those looking to dig deep into an asset's prospects. Analyst research often has quotes from company executives, questions from conference calls and in-depth reporting on the company's balance sheet, income statement and other essential documents. Analysis like this is complex for individual investors to do on their own, especially considering how frequently analysts interact with the executives they cover. But access often comes with a downside, which we discuss more below.

How Accurate Are Analyst Ratings?

Both buy and sell-side analysts strive for accuracy because giving consistently wrong commendations can be hazardous for job security. However, investors should be aware that analysts might not always have the best interest of the retail investor at heart when making their recommendations.

For starters, being an analyst requires access to company employees and management. Analysts typically ask questions during conference calls and speak with C-suite executives on the record about their firms' prospects. Executives usually don't want to hear adverse reports about their companies, so analysts are incentivized to paint a rosy picture to retain access. The SEC has been questioning the authenticity of analyst ratings (especially on the sell-side) since 2002 when it asked bluntly, "Why are there so few sell ratings?"

Of course, there are other areas of the securities analysis market to face scrutiny. If you recall, during the 2008 financial crisis, the biggest credit rating agencies were all held to the fire due to claims that conflicts of interest influenced their ratings. The biggest rating agencies in the world were accused of "misrepresenting the risks associated with mortgage-backed securities." Remember, analyst ratings aren't spat out by computer algorithms but by living, breathing people who may have agendas other than providing the most precise and accurate reports on a company's future prospects.

Analyst Ratings Can Guide Investors, but Don't Treat Them as Gospel

Consider each type of investment research or advice in collaboration. Even the most accurate and thoughtful analysts get things wrong, plus ratings are frequently besieged with conflicts of interest. But analyst coverage does offer research that's difficult to get elsewhere, and using an array of analyst reports can give investors a deeper understanding of the securities they buy.

FAQs

Still have questions about analyst ratings? Here are a few answers to some common points of discussion:

What are analyst ratings?

Analyst ratings are the "buy" and "sell" labels, plus price targets, that investment researchers attach to specific securities. These ratings are based on financial data, earnings reports and conversations with company executives.

Should you trust analyst ratings?

Analyst ratings provide plenty of helpful information, but you shouldn't use an analyst's "buy" rating as the sole reason you purchase a security. Analysts aren't immune to conflicts of interest or outside parties' influence, so ensure you always understand why a stock was labeled a "buy" or "sell."

What does an analyst rating tell you about a stock?

Ratings give investors the analyst's overall opinion about a particular stock and price targets based on the company's valuation and prospects. Analysts often attend conference calls, ask questions and provide in-depth information about companies that are difficult to acquire elsewhere.

analyst ratings Headlines

Top Headlines and Offers

View All

Stock Forecasts and Research Tools

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Price Forecasts for Popular Stocks

Top Stock Recommendations by Brokerage

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Stock Price Targets and Analyst Ratings